Fact CheckerSign in

NCT04247672Recruiting

The ATtune Knee Outcome Study

The ATtune Knee Outcome Study: Prospective Evaluation of a Novel Uncemented Rotating Platform Total Knee Arthroplasty

Source: ClinicalTrials.gov · Last updated 27 Apr 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.

Status (registry)
Recruiting
Study type
Observational
Enrollment
900 (estimated)
First submitted
20 Jan 2020
Start date
3 Feb 2020
Primary completion date
22 Jan 2024
Lead sponsor
Spaarne Gasthuis
NCT number
NCT04247672

What you commit to

  • Study type: Observational
  • Planned participants: 900
  • From 3 Feb 2020 to the primary completion date, 22 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unable or unwilling to sign informed consent and comply with follow-up
  • Indication for primary revision arthroplasty
  • Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)

Who the study is looking for

  • End-stage osteoarthritis of the knee warranting joint replacement therapy.
  • Indicated for an ATTUNE total knee system as part of regular clinical practice.
  • Capability and willingness to sign informed consent and comply with follow-up procedures.
  • Capable enough in Dutch or English to be able to understand study procedures

Age in the registry: 21 years to 90 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Spaarne Gasthuis
Coordinator of this site? Confirm its status
HoofddorpNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.